The goal of MINERVA is to understand how the immune system and genetic risk factors influence the activity of immune cells in the brain, the microglia, and their communication with neurons, and how these processes modulate neurodevelopmental alterations and the severity of autism spectrum disorder (ASD). The results of these studies will help to better understand the mechanisms of the immune system that are associated with ASD development and behavioral impairment. In addition, based on these results, innovative therapeutic approaches may be developed that target neuroimmune and behavioral deficits in ASD.

2022

2024